Screener
Assembly Biosciences ASMB Income Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $13.37M+38.9% | $8.21M-12.8% | $42.47M+477% | $10.79M+57.6% | $9.63M+12.8% | ||
| $14.92M-7.5% | $14.9M+0.3% | $17.25M+20.8% | $16.59M+22.7% | $16.13M-0.8% | ||
| $4.8M+4.5% | $4.68M+3.9% | $5.42M+17.6% | $5.09M+18.6% | $4.59M+2.6% | ||
| $19.72M-4.8% | $19.58M+1.2% | $22.67M+20.0% | $21.67M+21.7% | $20.72M-0.1% | ||
| -$6.34M+42.8% | -$11.37M-14.4% | —— | -$10.88M+0.7% | -$11.09M+9.1% | ||
| -47.4%+67.8pp | -138.4%-32.9pp | —— | -100.9%+59.2pp | -115.2%+27.8pp | ||
| $2.49M+178% | $2.29M+104% | $2.29M+104% | $1.69M+25.6% | $895K-38.6% | ||
| -$3.86M+62.2% | -$9.08M-3.0% | —— | -$9.2M+4.3% | -$10.2M+8.6% | ||
| -28.8%+77.1pp | -110.5%-16.9pp | —— | -85.2%+55.2pp | -105.9%+24.8pp | ||
| -$0.20+85.0% | -$0.54+53.8% | —— | -$0.72+52.3% | -$1.33+32.8% | ||
| -$6.32M+42.8% | -$11.34M-14.5% | —— | -$10.85M+0.7% | -$11.06M+9.1% | ||
| -47.3%+67.6pp | -138.1%-32.9pp | —— | -100.6%+59.0pp | -114.9%+27.7pp | ||
| -$6.34M+42.8% | -$11.37M-14.4% | —— | -$10.88M+0.7% | -$11.09M+9.1% |
FAQ
- What is Assembly Biosciences's revenue?
- Assembly Biosciences (ASMB) generated $74.8M in revenue over the trailing twelve months, up 125.1% year over year.
- Is Assembly Biosciences profitable?
- Assembly Biosciences is not currently profitable: it reported a net loss of $32.3M over the trailing twelve months, a -103.6% net margin.
- What is Assembly Biosciences's earnings per share?
- Assembly Biosciences's diluted EPS over the trailing twelve months is $-2.79.
- Where does Assembly Biosciences's income statement data come from?
- Every line is extracted from Assembly Biosciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
